BioWorld MedTech

March 20, 2014

View Archived Issues

Washington Roundup: NHLBI eyes TGF-beta as culprit in failure of saphenous vein graft

Court Report: Biolitec CEO a no-show in court, must pay $74.9M to AngioDynamics

HIT Roundup: Health Level introduces software solution for cardiology centers

Financings roundup: Augmedix gets venture funds to expand technology team

Product briefs

People in Places

MDD's Orthopedic Extra

Move could help quell chaotic market: China prepares to crack down on host of device rule breakers

Chinese authorities are taking action to tackle illegal sales and marketing activities in the medical devices as they work to consolidate a market that remains chaotic. Read More

The MDD Interview: Esaote seeks growth by expanding portfolio, markets

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...

Liver with hepatitis viruses, blood cells

Recombinant vaccine inhibits HBV-associated HCC growth

BioWorld Science

Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....